Xiaofei Jiang

3.2k citations

54 papers · 2.1k indexed · h-index 25

Impact in

Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Endocrinology top 1%
- Vibrio bacteria research studies
- Enterobacteriaceae and Cronobacter Research

Papers in ⓘ

Molecular Medicine 33
- Antibiotic Resistance in Bacteria 33
Endocrinology 16
- Vibrio bacteria research studies 9
- Escherichia coli research studies 5
- Infections and bacterial resistance 5

Co-authors: Yuan Lu (2 shared papers)Yuan Lu (8 shared papers)Dongxing Tian (13 shared papers)Ying Zhou (10 shared papers)Frank R. DeLeo (1 shared paper)Henry F. Chambers (1 shared paper)Michaël Otto (1 shared paper)Kevin R. Braughton (1 shared paper)
Journals: Frontiers in Cellular and Infection Microbiology (5 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)Journal of Clinical Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
Partner nations: China United Kingdom United States

In The Last Decade

Xiaofei Jiang

51 papers receiving 2.1k citations

Peers

Countries citing papers authored by Xiaofei Jiang

Since Specialization

Citations

This map shows the geographic impact of Xiaofei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Jiang more than expected).

Fields of papers citing papers by Xiaofei Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Jiang. The network helps show where Xiaofei Jiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaofei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaofei Jiang Line = papers co-authored together Xiaofei Jiang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus Proceedings of the National Academy of Sciences ·Min Li, Binh An Diep, Amer E. Villaruz, Kevin R. Braughton, Xiaofei Jiang, Frank R. DeLeo, Henry F. Chambers, Yuan Lu, Michaël Otto	2009	322
2	Resistance reported from China antimicrobial surveillance network (CHINET) in 2018 European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Fupin Hu, Yan Guo, Yang Yang, Yonggui Zheng, Shi Wu, Xiaofei Jiang, Demei Zhu, Fu Wang	2019	197
3	Complete Genome Sequence of Klebsiella pneumoniae subsp. pneumoniae HS11286, a Multidrug-Resistant Strain Isolated from Human Sputum Journal of Bacteriology ·Pinglei Liu, Peng Li, Xiaofei Jiang, Dexi Bi, Yingzhou Xie, Cui Tai, Zixin Deng, Kumar Rajakumar, Hong‐Yu Ou	2012	145
4	Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway Biomedicine & Pharmacotherapy ·Miao Sui, Xiaofei Jiang, Jun Chen, Haiyan Yang, Yan Zhu	2018	129
5	Detection of Extended-Spectrum β-Lactamases in Clinical Isolates of Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy ·Xiaofei Jiang, Zhe Zhang, Min Li, Danqiu Zhou, Fei-yi Ruan, Yuan Lu	2006	108
6	Prevalence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae under divergent evolutionary patterns Emerging Microbes & Infections ·Dongxing Tian, Xiao Liu, Wenjie Chen, Ying Zhou, Dakang Hu, Weiwen Wang, Jinzuan Wu, Qing Mu, Xiaofei Jiang	2022	89
7	Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors Endocrine Related Cancer ·Yong Lin, Xiaofei Jiang, Ye Shen, Min Li, Huili Ma, Mingzhao Xing, Yuan Lu	2008	79
8	Outbreak of Infection Caused by Enterobacter cloacae Producing the Novel VEB-3 Beta-Lactamase in China Journal of Clinical Microbiology ·Xiaofei Jiang, Yuxing Ni, Yanqun Jiang, Feiyi Yuan, Lizhong Han, Ming Li, Hong Liu, Yang Li, Yuan Lu	2005	67
9	Prevalence of Plasmid-Mediated AmpC β-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC β-Lactamase Resistance in China Journal of Clinical Microbiology ·Yi Li, Qing Li, Yuzhen Du, Xiaofei Jiang, Jin Tang, Jian‐Qiang Wang, Guilan Li, Yanqun Jiang	2008	66
10	VPS34 stimulation of p62 phosphorylation for cancer progression Oncogene ·Xiaofei Jiang, Yongrui Bao, Hongrui Liu, Xinhui Kou, Zhaoyun Zhang, Fanghui Sun, Zhong‐Ming Qian, Zhuofeng Lin, Xuefeng Li, Xiaoqiang Liu, Lan Jiang, Yujie Yang	2017	57
11	Contribution of β-Lactamases and Porin Proteins OmpK35 and OmpK36 to Carbapenem Resistance in Clinical Isolates of KPC-2-Producing Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy ·Ying Zhang, Xiaofei Jiang, Yanyan Wang, Gang Li, Yueru Tian, Hong Liu, Fuqi Ai, Yiming Ma, Bei Wang, Fei-yi Ruan, Kumar Rajakumar	2013	57
12	Mapping the resistance-associated mobilome of a carbapenem-resistantKlebsiella pneumoniaestrain reveals insights into factors shaping these regions and facilitates generation of a ‘resistance-disarmed’ model organism Journal of Antimicrobial Chemotherapy ·Dexi Bi, Xiaofei Jiang, Zi-Ke Sheng, David Ngmenterebo, Cui Tai, Minggui Wang, Zixin Deng, Kumar Rajakumar, Hong‐Yu Ou	2015	49
13	MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease Journal of Molecular and Cellular Cardiology ·Eliana C. Martinez, Shera Lilyanna, Peipei Wang, Leah A. Vardy, Xiaofei Jiang, Arunmozhiarasi Armugam, Kandiah Jeyaseelan, Mark Richards	2017	46
14	Identification of hypervirulent Klebsiella pneumoniae isolates using the string test in combination with Galleria mellonella infectivity European Journal of Clinical Microbiology & Infectious Diseases ·Gang Li, Jimin Shi, Yan Zhao, Yingzhou Xie, Yu Tang, Xiaofei Jiang, Yuan Lu	2020	46
15	Genetic diversity and evolution of the virulence plasmids encoding aerobactin and salmochelin in Klebsiella pneumoniae Virulence ·Dongxing Tian, Meng Wang, Ying Zhou, Dakang Hu, Hong‐Yu Ou, Xiaofei Jiang	2021	45
16	The type I-E CRISPR-Cas system influences the acquisition of bla _KPC -IncF plasmid in Klebsiella pneumonia Emerging Microbes & Infections ·Ying Zhou, Yu Tang, Pan Fu, Dongxing Tian, Lianhua Yu, Yunkun Huang, Gang Li, Meng Li, Yong Wang, Zehua Yang, Xiaogang Xu, Zhe Yin, Dongsheng Zhou, Laurent Poirel, Xiaofei Jiang	2020	43
17	Absence of the type I-E CRISPR-Cas system in Klebsiella pneumoniae clonal complex 258 is associated with dissemination of IncF epidemic resistance plasmids in this clonal complex Journal of Antimicrobial Chemotherapy ·Yu Tang, Pan Fu, Ying Zhou, Yingzhou Xie, Jialin Jin, Bei Wang, Lianhua Yu, Yunkun Huang, Gang Li, Meng Li, Wei Liang, Hong‐Yu Ou, Xiaofei Jiang	2019	40
18	Human Mesenchymal Stem Cell-derived Exosomes Reduce Ischemia/Reperfusion Injury by the Inhibitions of Apoptosis and Autophagy Current Pharmaceutical Design ·Xiaofei Jiang, Kar Sheng Lew, Qiying Chen, Mark Richards, Peipei Wang	2019	40
19	Salidroside inhibits high-glucose induced proliferation of vascular smooth muscle cells via inhibiting mitochondrial fission and oxidative stress Experimental and Therapeutic Medicine ·Xinyu Zhuang, Alimujiang Maimaitijiang, Yong Li, Haiming Shi, Xiaofei Jiang	2017	35
20	Acquisition of the Conjugative Virulence Plasmid From a CG23 Hypervirulent Klebsiella pneumoniae Strain Enhances Bacterial Virulence Frontiers in Cellular and Infection Microbiology ·Dongxing Tian, Weiwen Wang, Meng Li, Wenjie Chen, Ying Zhou, Yunkun Huang, Zi-Ke Sheng, Xiaofei Jiang	2021	32

About Xiaofei Jiang

Xiaofei Jiang is a scholar working on Molecular Medicine, Endocrinology, Clinical Biochemistry, Applied Microbiology and Biotechnology and Family Practice, having authored 54 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Genomics and Phylogenetic Studies (9 papers), Vibrio bacteria research studies (9 papers), Bacteriophages and microbial interactions (7 papers), Escherichia coli research studies (5 papers), Infections and bacterial resistance (5 papers), Bacterial biofilms and quorum sensing (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Endocrinology (460 citations), Applied Microbiology and Biotechnology (107 citations), Clinical Biochemistry (291 citations) and Infectious Diseases (446 citations). Xiaofei Jiang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yuan Lu, Yuan Lu, Dongxing Tian, Ying Zhou, Frank R. DeLeo, Henry F. Chambers, Michaël Otto, Kevin R. Braughton, Min Li and Amer E. Villaruz. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact